DNV001

· Hangzhou Dinovate Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DNV001, covering 2026-02-06 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: DNV001 Injection in Patients With Hypercholesterolemia [Phase 2]